CI Investments Inc’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Buy |
4,115
+1,894
| +85% | +$618K | 0.01% | 391 |
|
|
2025
Q1 | $600K | Sell |
2,221
-1,263
| -36% | -$341K | ﹤0.01% | 492 |
|
|
2024
Q4 | $820K | Sell |
3,484
-113
| -3% | -$26.6K | ﹤0.01% | 444 |
|
|
2024
Q3 | $989K | Sell |
3,597
-25
| -0.7% | -$6.87K | ﹤0.01% | 411 |
|
|
2024
Q2 | $880K | Sell |
3,622
-269
| -7% | -$65.4K | ﹤0.01% | 404 |
|
|
2024
Q1 | $582K | Buy |
3,891
+1,540
| +66% | +$230K | ﹤0.01% | 462 |
|
|
2023
Q4 | $450K | Sell |
2,351
-297
| -11% | -$56.8K | ﹤0.01% | 464 |
|
|
2023
Q3 | $469K | Sell |
2,648
-337
| -11% | -$59.7K | ﹤0.01% | 445 |
|
|
2023
Q2 | $567K | Buy |
2,985
+1,355
| +83% | +$257K | ﹤0.01% | 431 |
|
|
2023
Q1 | $327K | Buy |
1,630
+891
| +121% | +$179K | ﹤0.01% | 508 |
|
|
2022
Q4 | $176K | Buy |
739
+345
| +88% | +$82.2K | ﹤0.01% | 627 |
|
|
2022
Q3 | $79K | Buy |
394
+136
| +53% | +$27.3K | ﹤0.01% | 731 |
|
|
2022
Q2 | $38K | Sell |
258
-434
| -63% | -$63.9K | ﹤0.01% | 865 |
|
|
2022
Q1 | $113K | Buy |
692
+49
| +8% | +$8K | ﹤0.01% | 830 |
|
|
2021
Q4 | $109K | Buy |
643
+126
| +24% | +$21.4K | ﹤0.01% | 874 |
|
|
2021
Q3 | $98K | Buy |
+517
| New | +$98K | ﹤0.01% | 860 |
|
|
2020
Q3 | – | Sell |
-2,036
| Closed | -$302K | – | 928 |
|
|
2020
Q2 | $302K | Buy |
+2,036
| New | +$302K | ﹤0.01% | 454 |
|
|
2020
Q1 | – | Sell |
-3,220
| Closed | -$371K | – | 564 |
|
|
2019
Q4 | $371K | Buy |
+3,220
| New | +$371K | ﹤0.01% | 529 |
|